![Eyal S. Ron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eyal S. Ron
Technik-/Wissenschafts-/F&E-Leiter bei Polyrizon Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
John Schwartz | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 Jahre |
Tomer Izraeli | M | 46 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 19 Jahre |
Mark W. Grinstaff | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 Jahre |
Karen English | F | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 20 Jahre |
Raul Srugo | M | 60 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 Jahre |
Liron Carmel | M | 39 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 Jahre |
Oz Adler | M | 36 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 Jahre |
Yonah Kalfa | M | 42 |
PharMedica Ltd.
| - |
Peter Lui | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
Liat Sidi | F | 50 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | - |
Nir Ben Yosef | M | 48 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 Jahre |
Bill Keogh | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 3 Jahre |
Roy Borochov | M | 49 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 Jahre |
Tidhar Turgeman | M | 44 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 Jahre |
Daphna Avital | F | 57 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 Jahre |
Yehonatan Zalman Vinokur | M | 46 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Alain J. Hanover | M | 75 |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
Jesse Wolinsky | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Israel | 11 | 61,11% |
Vereinigte Staaten | 7 | 38,89% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eyal S. Ron
- Persönliches Netzwerk